Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Agena, HeartGenetics Ink Genetic Testing Comarketing Deal

Agena, HeartGenetics Ink Genetic Testing Comarketing Deal

Jul 18, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Agena Bioscience announced today that it has signed an agreement to market its MassArray Dx system with HeartGenetics' HeartDecode genetic testing software and cardiovascular assays.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Molecular Diagnostics

  1. President Biden Announces Plan to Expand SARS-CoV-2 Testing, Increase Capacity

  2. Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

  3. Molzym, Fraunhofer Developing Rapid Direct-From-Sample Sepsis Diagnostic Platform and Test

    Premium

  4. Invitae Prices $400M Common Stock Offering

  5. NASA Looking to Spin Out Breath Analysis Platform for Use in Diagnostics Applications

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.